ID   TLK1_HUMAN              Reviewed;         766 AA.
AC   Q9UKI8; Q14150; Q8N591; Q9NYH2; Q9Y4F6;
DT   22-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   22-AUG-2003, sequence version 2.
DT   05-OCT-2010, entry version 100.
DE   RecName: Full=Serine/threonine-protein kinase tousled-like 1;
DE            EC=2.7.11.1;
DE   AltName: Full=PKU-beta;
DE   AltName: Full=Tousled-like kinase 1;
GN   Name=TLK1; Synonyms=KIAA0137;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta, and Testis;
RX   MEDLINE=98087437; PubMed=9427565; DOI=10.1016/S0378-1119(97)00495-2;
RA   Yamakawa A., Kameoka Y., Hashimoto K., Yoshitake Y., Nishikawa K.,
RA   Tanihara K., Date T.;
RT   "cDNA cloning and chromosomal mapping of genes encoding novel protein
RT   kinases termed PKU-alpha and PKU-beta, which have nuclear localization
RT   signal.";
RL   Gene 202:193-201(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, MUTAGENESIS OF
RP   ASP-607, SUBCELLULAR LOCATION, INTERACTION WITH TLK2, AND ENZYME
RP   REGULATION.
RC   TISSUE=Placenta;
RX   MEDLINE=99452775; PubMed=10523312; DOI=10.1093/emboj/18.20.5691;
RA   Sillje H.H.W., Takahashi K., Tanaka K., Van Houwe G., Nigg E.A.;
RT   "Mammalian homologues of the plant tousled gene code for cell-cycle-
RT   regulated kinases with maximal activities linked to ongoing DNA
RT   replication.";
RL   EMBO J. 18:5691-5702(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   MEDLINE=20056088; PubMed=10588641;
RA   Cabaniols J.-P., Ravichandran V., Roche P.A.;
RT   "Phosphorylation of SNAP-23 by the novel kinase SNAK regulates t-SNARE
RT   complex assembly.";
RL   Mol. Biol. Cell 10:4033-4041(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   MEDLINE=96127530; PubMed=8590280; DOI=10.1093/dnares/2.4.167;
RA   Nagase T., Seki N., Tanaka A., Ishikawa K., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. IV.
RT   The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 2:167-174(1995).
RN   [5]
RP   SEQUENCE REVISION.
RX   MEDLINE=22158633; PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, INTERACTION WITH ASF1A AND ASF1B, AND MUTAGENESIS OF
RP   ASP-607.
RX   MEDLINE=21363240; PubMed=11470414; DOI=10.1016/S0960-9822(01)00298-6;
RA   Sillje H.H.W., Nigg E.A.;
RT   "Identification of human Asf1 chromatin assembly factors as substrates
RT   of Tousled-like kinases.";
RL   Curr. Biol. 11:1068-1073(2001).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION OF HISTONE H3.
RX   PubMed=11314006; DOI=10.1038/sj.onc.1204147;
RA   Li Y., DeFatta R., Anthony C., Sunavala G., De Benedetti A.;
RT   "A translationally regulated Tousled kinase phosphorylates histone H3
RT   and confers radioresistance when overexpressed.";
RL   Oncogene 20:726-738(2001).
RN   [9]
RP   FUNCTION, MUTAGENESIS OF SER-743, PHOSPHORYLATION AT SER-743, AND
RP   ENZYME REGULATION.
RX   MEDLINE=22546651; PubMed=12660173; DOI=10.1093/emboj/cdg151;
RA   Groth A., Lukas J., Nigg E.A., Sillje H.H.W., Wernstedt C., Bartek J.,
RA   Hansen K.;
RT   "Human tousled like kinases are targeted by an ATM- and Chk1-dependent
RT   DNA damage checkpoint.";
RL   EMBO J. 22:1676-1687(2003).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15302935; DOI=10.1073/pnas.0404720101;
RA   Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,
RA   Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
RT   "Large-scale characterization of HeLa cell nuclear phosphoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-179 AND SER-190, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74; THR-75; SER-77;
RP   THR-78; SER-80; SER-133; SER-138; SER-158; SER-159 AND SER-741, AND
RP   MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159 AND SER-741, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   VARIANT [LARGE SCALE ANALYSIS] CYS-121.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Rapidly and transiently inhibited by phosphorylation
CC       following the generation of DNA double-stranded breaks during S-
CC       phase. This is cell cycle checkpoint and ATM-pathway dependent and
CC       appears to regulate processes involved in chromatin assembly.
CC       Isoform 3 phosphorylates and enhances the stability of the t-SNARE
CC       SNAP23, augmenting its assembly with syntaxin. Isoform 3 protects
CC       the cells from the ionizing radiation by faciliting the repair of
CC       DSBs. In vitro, phosphorylates histone H3 at 'Ser-10'.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Cell-cycle regulated, maximal activity in S-
CC       phase. Inactivated by phosphorylation at Ser-743, potentially by
CC       CHK1.
CC   -!- SUBUNIT: Heterodimerizes with TLK2. Interacts with ASF1A and
CC       ASF1B.
CC   -!- INTERACTION:
CC       Q9NVP2:ASF1B; NbExp=1; IntAct=EBI-740492, EBI-1055650;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9UKI8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UKI8-2; Sequence=VSP_050571;
CC       Name=3; Synonyms=SNAK, TLK1B;
CC         IsoId=Q9UKI8-3; Sequence=VSP_050570;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Present in fetal placenta,
CC       liver, kidney and pancreas but not heart or skeletal muscle. Also
CC       found in adult cell lines. Isoform 3 is ubiquitously expressed in
CC       all tissues examined.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF03094.1; Type=Erroneous initiation;
CC       Sequence=BAA09486.2; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB004885; BAA20562.1; -; mRNA.
DR   EMBL; AF162666; AAF03094.1; ALT_INIT; mRNA.
DR   EMBL; AF246219; AAF71263.1; -; mRNA.
DR   EMBL; D50927; BAA09486.2; ALT_INIT; mRNA.
DR   EMBL; BC032657; AAH32657.1; -; mRNA.
DR   IPI; IPI00333559; -.
DR   IPI; IPI00339361; -.
DR   IPI; IPI00746072; -.
DR   RefSeq; NP_036422.3; -.
DR   UniGene; Hs.723175; -.
DR   ProteinModelPortal; Q9UKI8; -.
DR   SMR; Q9UKI8; 428-729.
DR   IntAct; Q9UKI8; 7.
DR   MINT; MINT-112025; -.
DR   STRING; Q9UKI8; -.
DR   PRIDE; Q9UKI8; -.
DR   Ensembl; ENST00000431350; ENSP00000411099; ENSG00000198586.
DR   GeneID; 9874; -.
DR   UCSC; uc002ugn.1; human.
DR   UCSC; uc002ugo.1; human.
DR   CTD; 9874; -.
DR   GeneCards; GC02M171812; -.
DR   HGNC; HGNC:11841; TLK1.
DR   HPA; HPA016043; -.
DR   MIM; 608438; gene.
DR   PharmGKB; PA36543; -.
DR   eggNOG; prNOG16352; -.
DR   HOVERGEN; HBG007938; -.
DR   OMA; TQPKQLS; -.
DR   OrthoDB; EOG96HJW9; -.
DR   PhylomeDB; Q9UKI8; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 37219; -.
DR   ArrayExpress; Q9UKI8; -.
DR   Bgee; Q9UKI8; -.
DR   CleanEx; HS_TLK1; -.
DR   Genevestigator; Q9UKI8; -.
DR   GermOnline; ENSG00000198586; Homo sapiens.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0016568; P:chromatin modification; IEA:UniProtKB-KW.
DR   GO; GO:0006886; P:intracellular protein transport; IDA:UniProtKB.
DR   GO; GO:0023034; P:intracellular signaling pathway; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   GO; GO:0001672; P:regulation of chromatin assembly or disasse...; IDA:UniProtKB.
DR   GO; GO:0006974; P:response to DNA damage stimulus; IEA:UniProtKB-KW.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell cycle; Chromatin regulator;
KW   Coiled coil; Complete proteome; DNA damage; Kinase;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    766       Serine/threonine-protein kinase tousled-
FT                                like 1.
FT                                /FTId=PRO_0000086752.
FT   DOMAIN      456    734       Protein kinase.
FT   NP_BIND     462    470       ATP (By similarity).
FT   COILED      230    281       Potential.
FT   COILED      397    445       Potential.
FT   ACT_SITE    586    586       Proton acceptor.
FT   BINDING     485    485       ATP (By similarity).
FT   MOD_RES      74     74       Phosphoserine.
FT   MOD_RES      75     75       Phosphothreonine.
FT   MOD_RES      77     77       Phosphoserine.
FT   MOD_RES      78     78       Phosphothreonine.
FT   MOD_RES      80     80       Phosphoserine.
FT   MOD_RES     133    133       Phosphoserine.
FT   MOD_RES     138    138       Phosphoserine.
FT   MOD_RES     158    158       Phosphoserine.
FT   MOD_RES     159    159       Phosphoserine.
FT   MOD_RES     179    179       Phosphothreonine.
FT   MOD_RES     190    190       Phosphoserine.
FT   MOD_RES     741    741       Phosphoserine.
FT   MOD_RES     743    743       Phosphoserine.
FT   VAR_SEQ       1    217       Missing (in isoform 3).
FT                                /FTId=VSP_050570.
FT   VAR_SEQ     136    136       G -> GFPNLPVFQSLAYWEMGRTAGG (in isoform
FT                                2).
FT                                /FTId=VSP_050571.
FT   VARIANT     121    121       R -> C.
FT                                /FTId=VAR_041215.
FT   MUTAGEN     607    607       D->A: Loss of kinase activity.
FT   MUTAGEN     743    743       S->A: Loss of kinase inhibition in
FT                                response to DNA damage.
FT   MUTAGEN     743    743       S->D: Loss of kinase inhibition in
FT                                response to DNA damage.
FT   MUTAGEN     743    743       S->E: Loss of kinase inhibition in
FT                                response to DNA damage.
FT   CONFLICT     88     88       S -> T (in Ref. 2; AAF03094).
FT   CONFLICT    102    102       G -> E (in Ref. 1; BAA20562).
FT   CONFLICT    230    230       Q -> L (in Ref. 1; BAA20562).
FT   CONFLICT    261    261       E -> D (in Ref. 1; BAA20562).
FT   CONFLICT    416    416       E -> G (in Ref. 1; BAA20562).
FT   CONFLICT    439    439       N -> H (in Ref. 1; BAA20562).
FT   CONFLICT    471    471       Y -> D (in Ref. 1; BAA20562).
FT   CONFLICT    477    477       Y -> S (in Ref. 1; BAA20562).
FT   CONFLICT    625    625       D -> V (in Ref. 1; BAA20562).
FT   CONFLICT    665    665       F -> Y (in Ref. 1; BAA20562).
FT   CONFLICT    730    730       N -> C (in Ref. 1; BAA20562).
SQ   SEQUENCE   766 AA;  86700 MW;  A65AE0A2A7C7FF2F CRC64;
     MSVQSSSGSL EGPPSWSQLS TSPTPGSAAA ARSLLNHTPP SGRPREGAMD ELHSLDPRRQ
     ELLEARFTGV ASGSTGSTGS CSVGAKASTN NESSNHSFGS LGSLSDKESE TPEKKQSESS
     RGRKRKAENQ NESSQGKSIG GRGHKISDYF EYQGGNGSSP VRGIPPAIRS PQNSHSHSTP
     SSSVRPNSPS PTALAFGDHP IVQPKQLSFK IIQTDLTMLK LAALESNKIQ DLEKKEGRID
     DLLRANCDLR RQIDEQQKLL EKYKERLNKC ISMSKKLLIE KSTQEKLSSR EKSMQDRLRL
     GHFTTVRHGA SFTEQWTDGF AFQNLVKQQE WVNQQREDIE RQRKLLAKRK PPTANNSQAP
     STNSEPKQRK NKAVNGAEND PFVRPNLPQL LTLAEYHEQE EIFKLRLGHL KKEEAEIQAE
     LERLERVRNL HIRELKRINN EDNSQFKDHP TLNERYLLLH LLGRGGFSEV YKAFDLYEQR
     YAAVKIHQLN KSWRDEKKEN YHKHACREYR IHKELDHPRI VKLYDYFSLD TDTFCTVLEY
     CEGNDLDFYL KQHKLMSEKE ARSIVMQIVN ALRYLNEIKP PIIHYDLKPG NILLVDGTAC
     GEIKITDFGL SKIMDDDSYG VDGMDLTSQG AGTYWYLPPE CFVVGKEPPK ISNKVDVWSV
     GVIFFQCLYG RKPFGHNQSQ QDILQENTIL KATEVQFPVK PVVSSEAKAF IRRCLAYRKE
     DRFDVHQLAN DPYLLPHMRR SNSSGNLHMA GLTASPTPPS SSIITY
//
